United Kingdom · Investor

Schroder Ventures

Last cheque observed Mar 2010. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietPrivate equity

SeedSeries ASeries B3D TechnologyConstructionInformation Technology

Cheques on record
0%of best year0cheques in 12 months, 18 on record
Since the last cheque6069days00hrs00min00sec
Median round$29MRounds led0 of 18Sole investor3 roundsExits5 from the portfolioMostly inUnited States, 60%
Pitch Schroder Ventures

Schroder Ventures highlights

  1. 01

    18 rounds on record

  2. 02

    Mostly Series A and Series B: 61% of its rounds

  3. 03

    Sole investor in 3 rounds, median $11M

  4. 04

    5 exits from the portfolio

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
3D TechnologyConstructionInformation Technology
Based in
London, United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first18 appearances

  1. 2010

    3 rounds

  2. Mar
    Venture · paidcontent.org$11MSole investor
  3. Mar
    GeoSentricSeries B · NL · paidcontent.org$11MSole investor
  4. Jan
    CeQurSeries A · CH · finsmes.com$30MWith 3 others
  5. 2008

    1 round

  6. Aug
    AEA TechnologySeries A · GB$6.5MSole investor
  7. 2007

    1 round

  8. Sept
    GeoSentricSeries A · NL · fiercewireless.com$13MWith 1 other
  9. 2006

    2 rounds

  10. Dec
    OrthomimeticsSeries A$5.0MWith 3 others
  11. Nov
    Seed · paidcontent.org$1.0MWith 18 others
  12. 2005

    1 round

  13. Oct
    LorantisSeries C · GB$44MWith 5 others
  14. 2004

    5 rounds

  15. Aug
    Avera PharmaceuticalSeries C · US$48MWith 10 others
  16. Jun
    RejuvenonSeries B · US$37MWith 5 others
  17. Jun
    Sadra MedicalSeries A · US$9.0MWith 2 others
  18. Apr
    Dynogen PharmaceuticalsSeries B · US$50MWith 4 others
  19. Apr
    ArchemixSeries B · US$50MWith 8 others
  20. 2003

    2 rounds

  21. Nov
    Auxilium PharmaceuticalsSeries D · US$43MWith 7 others
  22. Mar
    CellZomeVenture · DE$32MWith 5 others
  23. 2002

    1 round

  24. Jan
    Achillion PharmaceuticalsVenture · US$41MWith 10 others
  25. 2001

    1 round

  26. Aug
    InsuletSeries A · US$11MWith 2 others
  27. 2000

    1 round

  28. Oct
    ThoughtworksSeries A · US$28MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration24 named

AAAndreas Albert MarkwalderMember of the Board and Chief Executive OfficeriForm ADV
ALAndrew Lewis MoscowDirectoriForm ADV
BJBenedict Joel David NoahChief Compliance OfficeriForm ADV
BFBenno FluryMember of the BoardiForm ADV
CJChristopher James DurackDirecotor, Member of the BoardiForm ADV
CNChristopher Neil TaylorDirectoriForm ADV
DMDaniel Max GrunigGeneral CounseliForm ADV
DDDirk DillingerHead of FinanceiForm ADV
DHDirk Hans Klaus LohmannMember of the BoardiForm ADV
DPDominic Peter Corti EmmersonChair - Director - ManageriForm ADV
GDGavin Douglas Lewis RalstonBoard MemberiForm ADV
GSGraham StaplesBoard MemberiForm ADV
HLHelen Louise FitzgeraldChief Financial Officer - DirectoriForm ADV
JFJames Finbarr BrowneBoard Member, Chief Executive Officer, Conducting OfficeriForm ADV
JPJames PriestmanDirectoriForm ADV
JJJerome Jean-Francois DucheneConducting Officer, Head of TechnologyiForm ADV
JKJohn Kenneth William HennesseyBoard MemberiForm ADV
KSKarine SzenbergChairman of the BoardiForm ADV
KTKazuhiro ToyodaHead of Japanese Equities, Direcotor, Member of the BoardiForm ADV
LMLisa Marie HornbyDirectoriForm ADV
MVMarcel VogtChief Operating OfficeriForm ADV
MSMike SommerBoard Member, Conducting Officer, Head of Risk & ComplianceiForm ADV
NKNoriaki KurosePresident, Chief Executive OfficeriForm ADV
OTOluremi Tolulope OlupitanMember of the BoardiForm ADV

We also hold 38 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$247Bassets it manages, 5 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Schroder Wealth Management (us) Limited
SEC number
CRD 299812

Funds on its Form ADV

20 private funds, $8.3B in gross assets · filed Sept 2024

Securitised assets 12Multi-asset 2Emerging markets 1

  1. Schroders Capital Securitized HI-Grade Flexible Total Return, L.P.Securitised assets4 investors$1.3B
  2. Schroder Emerging Markets FundEmerging markets13 investors$1.2B
  3. Schroder Focus II Master A, L.P.Securitised assets44 investors$1.1B
  4. Schroder Focus II Master B, L.P.Securitised assets44 investors$1.1B
  5. Schroder Diversified Growth Portfolio L.P.Multi-asset10 investors$694M
  6. Schroder TAFT-Hartley Income (Cayman), L.P.Securitised assets29 investors$527M
  7. Schroder TAFT-Hartley Income REIT, LLCSecuritised assets29 investors$527M
  8. Schroder Flexible Secured Income Master A, L.P.Securitised assets5 investors$417M
  9. Schroder Flexible Secured Income Master B, L.P.Securitised assets5 investors$417M
  10. Schroder Emerging Markets Equity Alpha FundEmerging markets equity5 investors$350M

And 10 more on the filing.

Exits from the portfolio

Companies it backed that were later bought or listed5 in all

Auxilium PharmaceuticalsBought by Endo Health Solutions$2.6BOct 2014
AEA TechnologyBought by Ricardo-AEAUndisclosedNov 2012
OrthomimeticsBought by TiGenixUndisclosedNov 2011
Sadra MedicalBought by Boston Scientific$193MNov 2010
Auxilium PharmaceuticalsListedUndisclosedDec 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Market Place MediaUndisclosedJul 2001

Who they invest alongside

The investors most often in the same rounds as Schroder Ventures. A count of rooms they were both in, not a relationship either has claimed.

Mentioned on podcasts

Episodes that name Schroder Ventures in their description, not their title.

Quick answers about Schroder Ventures

What does Schroder Ventures invest in?

Schroder Ventures invests most often at Series A and Series B (61% of the rounds on record), in sectors such as 3D Technology, Construction and Information Technology.

How active is Schroder Ventures?

18 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2010.

How big are Schroder Ventures's cheques?

The median round it joins is $29M.

Does Schroder Ventures lead rounds?

Rarely, if at all: none of its 18 investments on record names it as the lead.

Where does Schroder Ventures invest?

Most of the companies it backs are in the United States (60%), the Netherlands (13%) and the United Kingdom (13%).

Is Schroder Ventures investing now?

No investments in the last 12 months; the latest was in Mar 2010.

Who does Schroder Ventures invest alongside?

Most often Atlas Venture (4 rounds together), Abingworth (2 rounds together) and Advent International (2 rounds together).

What kind of investor is Schroder Ventures?

Schroder Ventures is a private equity firm based in London, United Kingdom.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it